Maya Leiva, PharmD, BCOP is a Hematology and Oncology Advanced Practice Pharmacist and holds a Board Certification in Oncology Pharmacy. Dr. Leiva received her pharmacy degree at Loma Linda University School of Pharmacy in 2010. Prior to pharmacy school, she completed her B.S. in Microbiology and was an NIH Fellow in the RISE program while pursuing her M.S. in Microbiology. In addition to practicing in three states, she has held multiple faculty appointments at pharmacy schools across the U.S. She has served as a preceptor to pharmacy students and pharmacy and medical residents and fellows. Dr. Leiva has subspecialties in supportive care, immunology, clinical informatics, disaster preparedness, oncology stewardship, and health equity. She most recently assisted the Inova health System to complete its first Health Equality Index survey through the Human Rights Campaign. Dr. Leiva is a Clinical Pharmacist Leader with the National Disaster Medical System through the Department of Health and Human Services. This position enables her to be deployed as part of a federal disaster response in the event of a local, regional, national, or international crisis. Her clinical research interests include the use of phytocannabinoids in the supportive care of cancer patients, optimizing supportive care measures for patients experiencing treatment related toxicities, LGBTQIA+ specific health needs, reducing health disparities among historically marginalized communities spanning from cancer screening to diagnosis and treatment, and implementation of oncology stewardship to reduce financial toxicities to patients and health care. Dr. Leiva is affiliated with West Coast University School of Pharmacy as an Associate Professor of Pharmacy Practice and is the Director of Infusion Services for Bass Comprehensive Cancer Center in Walnut Creek, California. Dr.Leiva is spearheading a Cancer Health Equity Program within Bass to reduce health disparities and improve care for patients.
Medical School: Loma Linda University School of Pharmacy
Harb, M., Leiva, M. Exploring Medication Adherence Strategies in the Context of Social Determinants: Literature Review. Poster Session presented at ASHP Midyear Clinical Meeting 2023. Dec 4th, 2023; Anaheim, CA.
Hindi, Mirna., Leiva, M. Doxycycline post-exposure prophylaxis: a systematic review of use and effectiveness among people at high risk of syphilis, gonorrhea and chlamydia infection. Poster Session presented at ASHP Midyear Clinical Meeting 2023. Dec 4th, 2023; Anaheim, CA.
Nadybal, M., Leiva, M. Risk Factors of Gastroparesis with Concurrent Use of GLP-1 Receptor Agonists. Poster Session presented at ASHP Midyear Clinical Meeting 2023. Dec 4th, 2023; Anaheim, CA.
Kolyaei, M., Leiva, M. A Systematic Review to Determine Safety of Probiotics in Immunocompromised Patient. Poster Session presented at ASHP Midyear Clinical Meeting 2023. Dec 4th, 2023; Anaheim, CA.
2023. June 27th. Leiva, M. Grand Rounds: Clinical Considerations for LGBTQIA+ Patients. Memorial Sloan Kettering, NY, NY U.S.
Yamauchi, S., Leiva, M. The Impact of Clinical Equations on Carboplatin Dosing: A Systematic Review to Determine Appropriate Dosing of Carboplatin in Adult Cancer Patients. Accepted ASCO 2023 e-abstract.
Leiva, M., Takemoto, J. 2022. Chapter 36 – Immunosuppressants in Solid Organ Transplant.
In S Whalen (ed). Lippincott's Illustrated Reviews: Pharmacology (8e).
Sands, J. and Maya Leiva, hosts. “Exploring Drug Shortages in the U.S.: What Do We Need to Know?” Project Oncology, 24th June 2022, ReachMD.
https://reachmd.com/programs/project-oncology/exploring-drug-shortages-in-the-us-what-do-we-need-to-know/13765/.
Sands, J. and Maya Leiva, hosts. “Bridging the Gaps in Care: How to Improve Care for LGBTQ+ Patients.” Project Oncology, 21st June 2022, ReachMD.
https://reachmd.com/programs/project-oncology/bridging-the-gaps-in-care-how-to-improve-care-for-lgbtq-patients/13766/.
Bossaer, J and Maya Leiva, hosts. “LGBTQ Clinical Pearls.”OncoPharm, 2nd June 2022, Apple Podcasts.
https://podcasts.apple.com/us/podcast/oncopharm/id1305345744?i=1000566656300.
Bossaer,J and Maya Leiva, hosts. “Transgender Cancer Screening.” OncoPharm. 2nd June 2022, Apple Podcasts.
https://podcasts.apple.com/us/podcast/oncopharm/id1305345744?i=1000564997794.
Gilbert, M., Leon, R., Moore, S., Nisbett, N., Sailor, S., Leiva, M. Chapter 21 - Using Students and Practitioners for Interprofessional Collaboration and Education (SPICE) to Tackle the Opioid Epidemic in California’s Fresno County. Interprofessional Collaboration in Parks, Recreation, and Human Services: Theory and Cases. Hironaka-Juteau, J., Lankford, S. Sagamore. 2022.
Pennisi, A., Harnden, K., Rizzo, P., Mauro, L., Khang, G., Leiva, M., Yom, S. Standardization of Informed Consent for Oral Chemotherapeutic Agents. American Society of Clinical Oncology (ASCO) Annual Conference. E-publication. J Clin Oncol 40, 2022 (suppl 16; abstr e18665).
Jeon, C., Leiva, M. Impact of an Internal Specialty Pharmacy Medication Assistance Program on the Adherence Rates of Oral Oncolytics. American Society of Clinical Oncology (ASCO) Annual Conference. E-publication. J Clin Oncol 40, 2022 (suppl 16; abstr e18576).
Leiva, M., Pennisi, A., Harnden, K., Rizzo, P., Mauro, L. The Feasibility of Same Day Pegfilgrastim-cbqv Administration in Breast Cancer Patients Receiving Myelosuppressive Chemotherapy Regimens at a Northern Virginia Cancer Center. J Clin Oncol 30, 2021 (suppl 15; abstr e18687).
Leiva, M., Wolters T. 2018. “Is Prescribing Oral Oncolytics an Art or Science?” White Paper.
Inova Schar Cancer Institute and NotifiUS, Nov 1
